基本説明
中皮腫の疫学、診断、組織病理、放射線診断、外科、化学療法、アスベスト繊維の発癌性他、様々なトピックを包括的に収録。
Contents: Section I: Clinical Features of Mesothelioma; II: Biology of Mesothelioma; III: Treatment Strategies.
Full Description
Malignant pleural mesothelioma, a malignancy due largely to asbestos exposure, represents an increasingly common challenge to clinical and medical oncologists, respiratory physicians, and cardiothoracic surgeons, as well as researchers in the field. The disease has yet to reach its peak and is expected to kill over 100,000 people worldwide. As malignant pleural mesothelioma gains in profile, Kenneth O'Byrne and Valerie Rusch present a comprehensive overview of the subject, aimed at all health care professionals who come into contact with patients with the disease.
The book includes chapters on epidemiology, diagnosis, histopathology, radiology, surgery, chemotherapy, immune therapy, radiotherapy, and palliative medicine, written by an international team of contributors. A molecular biology section focuses on the carcinogenic effects of asbestos fibres and simian virus 40, angiogenesis and angiogenic growth factors, the immune response, and genetic abnormalities detected in the disease. Future therapies are also covered, as is a perspective on the distinct legal issues related to the disease. This highly-illustrated, full colour book provides the ultimate, timely resource on this devastating disease.
Contents
SECTION 1. CLINICAL FEATURES OF MESOTHELIOMA ; 1. The Epidemiology and Aetiology of Malignant Mesothelioma ; 2. Epidemiological Snapshots From Around the World ; 3. Clinical Presentation, Radiological Evaluation and Diagnosis ; 4. Histopathology of Malignant Pleural Mesothelioma ; 5. Clinico-Pathological Prognostic Factors & Scoring Systems in Malignant Pleural Mesothelioma ; SECTION 2. BIOLOGY OF MESOTHELIOMA ; 6. Carcinogenic Mechanisms in Mesothelioma: Effects of asbestos on cell signal events, transcription factors, and inflammatory cytokines ; 7. Viral Factors in the Pathogenesis of Malignant Mesothelioma ; 8. Growth Factors, Cyclooxygenease-2 and Matrix Metalloproteinases in Malignant Mesothelioma ; 9. Vascularisation in Malignant Mesothelioma ; 10. Immunobiology of Malignant Mesothelioma ; 11. Cytogenetic and Molecular Genetic Changes in Malignant Mesothelioma ; SECTION 3. TREATMENT STRATEGIES ; 12. The Role of Surgery for Diagnosis, Staging and Symptom Control in Malignant Pleural Mesothelioma ; 13. Surgical and Multimodality Approaches to the Management of Operable Malignant Mesothelioma ; 14. Systemic Chemotherapy for Malignant Pleural Mesothelioma ; 15. Radiotherapy for Mesothelioma ; 16. Immunotherapy for Malignant Mesothelioma ; 17. Intra-thoracic Photodynamic Diagnosis and Treatment with Photodynamic Therapy or Hyperthermia of Malignant Mesothelioma ; 18. Novel Therapies for Mesothelioma ; 19. Gene Therapy for Malignant Pleural Mesothelioma ; 20. Palliative Care for Mesothelioma ; 21. The Treatment of Mesothelioma Cases in the American and United Kingdom Legal Systems
